132 related articles for article (PubMed ID: 3054626)
21. A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy.
Mendel CM; Klein RF; Chappell DA; Dere WH; Gertz BJ; Karam JH; Lavin TN; Grunfeld C
JAMA; 1986 Feb; 255(5):637-9. PubMed ID: 3511312
[TBL] [Abstract][Full Text] [Related]
22. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
[TBL] [Abstract][Full Text] [Related]
23. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.
Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM
Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532
[TBL] [Abstract][Full Text] [Related]
24. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.
Ondo WG; Fayle R; Atassi F; Jankovic J
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1636-9. PubMed ID: 16291885
[TBL] [Abstract][Full Text] [Related]
25. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.
Reimherr FW; Chouinard G; Cohn CK; Cole JO; Itil TM; LaPierre YD; Masco HL; Mendels J
J Clin Psychiatry; 1990 Dec; 51 Suppl B():18-27. PubMed ID: 2258378
[TBL] [Abstract][Full Text] [Related]
26. Chronic tension headache--treated with amitriptyline--a double-blind study.
Diamond S; Baltes BJ
Headache; 1971 Oct; 11(3):110-6. PubMed ID: 4940167
[No Abstract] [Full Text] [Related]
27. Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline.
Guelfi JD; Pichot P; Dreyfus JF
Neuropsychobiology; 1989; 22(1):41-8. PubMed ID: 2700774
[TBL] [Abstract][Full Text] [Related]
28. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
Smith KM; Eyal E; Weintraub D;
JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
[TBL] [Abstract][Full Text] [Related]
29. A randomized, placebo-controlled clinical trial of chiropractic and medical prophylactic treatment of adults with tension-type headache: results from a stopped trial.
Vernon H; Jansz G; Goldsmith CH; McDermaid C
J Manipulative Physiol Ther; 2009 Jun; 32(5):344-51. PubMed ID: 19539116
[TBL] [Abstract][Full Text] [Related]
30. Treatment of posttraumatic stress disorder with amitriptyline and placebo.
Davidson J; Kudler H; Smith R; Mahorney SL; Lipper S; Hammett E; Saunders WB; Cavenar JO
Arch Gen Psychiatry; 1990 Mar; 47(3):259-66. PubMed ID: 2407208
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.
Ondo WG; Tintner R; Voung KD; Lai D; Ringholz G
Mov Disord; 2005 Aug; 20(8):958-63. PubMed ID: 15800937
[TBL] [Abstract][Full Text] [Related]
32. Migraine prophylaxis. A comparison of propranolol and amitriptyline.
Ziegler DK; Hurwitz A; Hassanein RS; Kodanaz HA; Preskorn SH; Mason J
Arch Neurol; 1987 May; 44(5):486-9. PubMed ID: 3579659
[TBL] [Abstract][Full Text] [Related]
33. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.
Katzenschlager R; Poewe W; Rascol O; Trenkwalder C; Deuschl G; Chaudhuri KR; Henriksen T; van Laar T; Spivey K; Vel S; Staines H; Lees A
Lancet Neurol; 2018 Sep; 17(9):749-759. PubMed ID: 30055903
[TBL] [Abstract][Full Text] [Related]
34. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
[TBL] [Abstract][Full Text] [Related]
35. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings.
Göbel H; Hamouz V; Hansen C; Heininger K; Hirsch S; Lindner V; Heuss D; Soyka D
Pain; 1994 Nov; 59(2):241-249. PubMed ID: 7892022
[TBL] [Abstract][Full Text] [Related]
36. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
Smith WT; Glaudin V; Panagides J; Gilvary E
Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
[TBL] [Abstract][Full Text] [Related]
37. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.
Pal E; Nagy F; Aschermann Z; Balazs E; Kovacs N
Mov Disord; 2010 Oct; 25(14):2311-7. PubMed ID: 20740485
[TBL] [Abstract][Full Text] [Related]
38. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
[TBL] [Abstract][Full Text] [Related]
39. Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Staal-Schreinemachers AL; Wesseling H; Kamphuis DJ; vd Burg W; Lakke JP
Neurology; 1986 Feb; 36(2):291-3. PubMed ID: 3511405
[TBL] [Abstract][Full Text] [Related]
40. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]